[go: up one dir, main page]

ZA200903648B - Process for the preparation of abacavir - Google Patents

Process for the preparation of abacavir

Info

Publication number
ZA200903648B
ZA200903648B ZA200903648A ZA200903648A ZA200903648B ZA 200903648 B ZA200903648 B ZA 200903648B ZA 200903648 A ZA200903648 A ZA 200903648A ZA 200903648 A ZA200903648 A ZA 200903648A ZA 200903648 B ZA200903648 B ZA 200903648B
Authority
ZA
South Africa
Prior art keywords
abacavir
preparation
compound
reacting
compound obtained
Prior art date
Application number
ZA200903648A
Other languages
English (en)
Inventor
Ruperez Jorge Medrano
Pardo Julio Campon
Rius Laia Elias
Maimo Ramon Berenguer
Original Assignee
Esteve Quimica Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Esteve Quimica Sa filed Critical Esteve Quimica Sa
Publication of ZA200903648B publication Critical patent/ZA200903648B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/22Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one sulfur atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/16Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA200903648A 2006-12-21 2007-12-20 Process for the preparation of abacavir ZA200903648B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06126797A EP1939196A1 (en) 2006-12-21 2006-12-21 Process for the preparation of abacavir

Publications (1)

Publication Number Publication Date
ZA200903648B true ZA200903648B (en) 2010-08-25

Family

ID=37912446

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200903648A ZA200903648B (en) 2006-12-21 2007-12-20 Process for the preparation of abacavir

Country Status (18)

Country Link
US (1) US8097723B2 (xx)
EP (2) EP1939196A1 (xx)
JP (1) JP5166438B2 (xx)
KR (1) KR20090094025A (xx)
CN (1) CN101563346B (xx)
AT (1) ATE473979T1 (xx)
AU (1) AU2007336195A1 (xx)
CA (1) CA2670432A1 (xx)
DE (1) DE602007007824D1 (xx)
ES (1) ES2348197T3 (xx)
IL (1) IL198965A (xx)
MX (1) MX2009006231A (xx)
NO (1) NO20092375L (xx)
PL (1) PL2125814T3 (xx)
RU (1) RU2447073C2 (xx)
SI (1) SI2125814T1 (xx)
WO (1) WO2008074874A1 (xx)
ZA (1) ZA200903648B (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1905772A1 (en) * 2006-09-28 2008-04-02 Esteve Quimica, S.A. Process for the preparation of abacavir
EP2085397A1 (en) 2008-01-21 2009-08-05 Esteve Quimica, S.A. Crystalline form of abacavir
EA028518B1 (ru) * 2012-01-03 2017-11-30 Селлсьютикс Корпорейшн Карбоциклические нуклеозиды, их фармацевтическое применение и композиции
CN104788451A (zh) * 2014-01-21 2015-07-22 浙江九洲药业股份有限公司 一种阿巴卡韦的制备方法
CN109239253B (zh) * 2018-09-21 2021-07-09 江苏威奇达药业有限公司 一种阿巴卡韦的杂质的高效液相检测方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY104575A (en) * 1989-12-22 1994-04-30 The Wellcome Foundation Ltd Therapeutic nucleosides.
GB9402161D0 (en) * 1994-02-04 1994-03-30 Wellcome Found Chloropyrimidine intermediates
GB0320738D0 (en) * 2003-09-04 2003-10-08 Glaxo Group Ltd Novel process
EP1905772A1 (en) * 2006-09-28 2008-04-02 Esteve Quimica, S.A. Process for the preparation of abacavir
WO2008072074A1 (en) * 2006-12-11 2008-06-19 Aurobindo Pharma Limited An improved process for the preparation of purine derivative
EP2170840A1 (en) * 2007-06-21 2010-04-07 Aurobindo Pharma Ltd An improved process for preparing purine derivative

Also Published As

Publication number Publication date
NO20092375L (no) 2009-07-21
ATE473979T1 (de) 2010-07-15
WO2008074874A1 (en) 2008-06-26
ES2348197T3 (es) 2010-12-01
AU2007336195A1 (en) 2008-06-26
KR20090094025A (ko) 2009-09-02
DE602007007824D1 (de) 2010-08-26
IL198965A0 (en) 2010-02-17
CN101563346A (zh) 2009-10-21
JP2010513410A (ja) 2010-04-30
MX2009006231A (es) 2009-06-22
SI2125814T1 (sl) 2010-12-31
JP5166438B2 (ja) 2013-03-21
EP2125814A1 (en) 2009-12-02
RU2447073C2 (ru) 2012-04-10
CN101563346B (zh) 2011-07-27
US20100041883A1 (en) 2010-02-18
RU2009128032A (ru) 2011-01-27
EP1939196A1 (en) 2008-07-02
CA2670432A1 (en) 2008-06-26
PL2125814T3 (pl) 2010-12-31
US8097723B2 (en) 2012-01-17
EP2125814B1 (en) 2010-07-14
IL198965A (en) 2012-08-30

Similar Documents

Publication Publication Date Title
IL196894A0 (en) Process for preparing 3-dihalomethylpyrazole-4-carboxylic acid derivatives
NZ598012A (en) Processes for the preparation of 1,2,4-oxadiazole benzoic acids
MX2009001816A (es) Procedimiento para la produccion de acido d,l-2-hidroxi-4-alquilti o butirico.
CA2662080A1 (en) A process for the manufacture of snac (salcaprozate sodium)
NZ600119A (en) Process and intermediates for the preparation of 5-biphenyl-4-yl-2-methylpentanoic acid derivatives
IL198965A0 (en) Process for preparation of abacavir
WO2006127893A3 (en) Processes for production of 4-(biphenylyl)azetidin-2-one phosphonic acids
WO2011077140A3 (en) Method of producing acrylic and methacrylic acid
TW200730535A (en) Method for producing ketimine structure-containing alkoxysilane
NO20073602L (no) Fremgangsmate for fremstilling av hoyrent meloksikam og meloksikamkaliumsalt
BRPI0507422A (pt) processo para produção de ácido 2,5-dimetilfenilacético
WO2009084028A3 (en) Improved process for manufacturing anhydrous (e)-3-[2-butyl-1- {(4-carboxyphenyl) methyl}-1h-imidazole-5-yl]-(thiophen-2- ylmethyl)prop-2-enoic acid methane sulfonate
MX2010001191A (es) Procedimeinto para la produccion de un compuesto de toluidina.
WO2009093258A3 (en) A new and improved process for the preparation of ibandronate sodium monohydrate
WO2009006066A3 (en) Process for the preparation of benzimidazol thienylamine compounds and intermediates thereof
WO2011096697A3 (en) Process for preparing voriconazole by using new intermediates
WO2007051828A3 (en) Process for the preparation of a leukotriene antagonist and intermediates thereof
UA102091C2 (ru) Способ получения сульфонилпиролов как ингибиторов hdac
WO2008056378A3 (en) Novel process for the preparation of naratriptan hydrochloride
WO2009072139A8 (en) Process for producing 2-[1-methyl-5-(4-methylbenzoyl)- pyrrol-2- yl]acetic acid or salt thereof
WO2011070179A8 (en) Process for the preparation of propionic acid derivatives
WO2008152518A3 (en) Process for the preparation of risedronic acid or risedronate sodium
RU2007140651A (ru) Способ получения ортохлорбензиламина
UA89004C2 (ru) Способ получения 1-арил-3,4-пиразолдикарбоновых кислот
RU2006117723A (ru) Способ получения 4,4-диметокси-2,3,5-трихлорциклопент-2-ен-1-она